<DOC>
	<DOCNO>NCT01859624</DOCNO>
	<brief_summary>Albuterol drug approve US Food Drug Administration ( FDA ) treat breathe problem asthma . Studies show albuterol may beneficial improve muscle function people late-onset Pompe disease . The purpose study evaluate whether albuterol safe effective improve muscle function people late-onset Pompe disease , whether receive enzyme replacement therapy ( ERT ) . For study , albuterol consider investigational drug . The word `` investigational '' mean albuterol approve FDA individual late-onset Pompe disease .</brief_summary>
	<brief_title>Albuterol Individuals With Late Onset Pompe Disease ( LOPD )</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>1 . Diagnosis Pompe disease blood acid alphaglucosidase ( GAA ) assay GAA gene sequence 2 . Age : 18+ year enrollment 1 . Continuous invasive ventilation ( via tracheostomy endotracheal tube ) 2 . Clinically relevant illness within two week enrollment include fever &gt; 38.2o C , vomit 24 hour , seizure , symptom deem contraindicative new therapy . 3 . Chronic heart disease ( Myocardial infarction , arrythmia , cardiomyopathy ) 4 . History seizure disorder 5 . Hypothyroidism 6 . Pregnancy/Breast Feeding [ Women childbearing potential must negative urine pregnancy test study visit . In addition , Screening/Baseline woman childbearing potential must use medically acceptable contraceptive least 3 month prior study enrollment OR subject ) regular menstrual cycle , b ) Day 1 ( onset menses ) current cycle know , c ) urine pregnancy test administer within first two week current cycle ( Days 1 14 ) ] . The urine pregnancy test administer interpreted Stephanie Dearmey , Physician Assistant ( PAC ) , complete training Department Obstetrics Gynecology . Mrs. Dearmey use commercially available test kit specify pointofcare test policy . If criterion urine pregnancy test meet Screening/Baseline visit , blood pregnancy test do . 7 . Patients nonstandard schedule ERT ; example , weekly infusion oppose infusion every two week . The use follow concommitant med prohibit study : diuretic ( water pill ) ; digoxin ( digitalis , Lanoxin ) ; betablockers atenolol ( Tenormin ) , metoprolol ( Lopressor ) , propranolol ( Inderal ) ; tricyclic antidepressant amitriptyline ( Elavil , Etrafon ) , doxepin ( Sinequan ) , imipramine ( Janimine , Tofranil ) , nortriptyline ( Pamelor ) ; Monoamine oxidase ( MAO ) inhibitor isocarboxazid ( Marplan ) , phenelzine ( Nardil ) , rasagiline ( Azilect ) , selegiline ( Eldepryl , Emsam ) , tranylcypromine ( Parnate ) ; bronchodilator levalbuterol ( Xopenex ) , bitolterol ( Tornalate ) , pirbuterol ( Maxair ) , terbutaline ( Brethine , Bricanyl ) , salmeterol ( Serevent ) , isoetherine ( Bronkometer ) , metaproterenol ( Alupent , Metaprel ) , isoproterenol ( Isuprel Mistometer ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>LOPD</keyword>
	<keyword>Pompe Disease</keyword>
</DOC>